Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome
CompletedNot applicableNCT04275297
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a severe pain condition affecting 3-8 million people in the United States lacking treatments that work. Emotional suffering is common in IC/BPS and known to make physical symptoms worse, and studies show patient sub-groups respond differently to treatment. By creating and testing a psychosocial intervention specific to IC/BPS, we will learn if this intervention improves patient wellness, who the intervention works best for, and how the body's pain processing influences outcomes.
Study details
- Official title
- Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome
- Conditions
- Chronic Interstitial Cystitis
- Bladder Pain Syndrome
- Cystitis, Interstitial
- Painful Bladder Syndrome
- Cystitis, Chronic Interstitial
- Interstitial Cystitis
- Interstitial Cystitis, Chronic
- Interstitial Cystitis (Chronic) With Hematuria
- Interstitial Cystitis (Chronic) Without Hematuria
- Chronic Prostatitis
- Chronic Prostatitis With Chronic Pelvic Pain Syndrome
- Interventions
- Behavioral: Psychosocial Treatment
- Behavioral: Attention Control
- Sponsor
- Vanderbilt University Medical Center
- Collaborators
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Start date
- 2020-07-13
- Primary completion
- 2022-06-16
- Sex
- All
- Age range
- from 18 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * 18 years of age or older * Diagnosis of IC/BPS as given by providers or indicated by assessments Exclusion Criteria: * Comorbid neurological conditions including spinal cord injury or systematic neurologic illnesses, or central nervous system diseases such as brain tumor or stroke * Current or history of diagnosis of primary psychotic or major thought disorder within the past five years * Hospitalization for psychiatric reasons other than suicidal ideation, homicidal ideation, and/or PTSD (within the past 5 years) * Psychiatric or behavioral conditions in which symptoms are unstable or severe (e.g. current delirium, mania, psychosis, suicidal ideation, homicidal ideation, substance abuse dependency) reported within the past six months * Non-English speaking * Presenting symptoms at time of screening that would interfere with participation, specifically active suicidal ideation with intent to harm oneself or active delusional or psychotic thinking * Difficulties or limitations communicating over the telephone * Any planned life events that would interfere with participating in the key elements of the study * Any major active medical issues that could preclude participation * Currently being treated for cancer * Cancer-related pain * Currently engaged in individual counseling/psychotherapy or unwilling to pause this treatment for the trial duration
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04275297